LRP2 and type 2 diabetes mellitus: Circulating lipopolysaccharide levels are usually increased in patients with type 2 diabetes and/or obesity, and lipopolysaccharide has been reported to suppress megalin expression through the induction of TNFα expression in cultured PTECs35.